Health grants

Expected Outcome: Proposals submitted to this call are expected to address several of the following elements: • Scaling of wafer-level photonic processes for key materials (e.g. SiN, InP, GaAs),including process integration, yield optimisation, and manufacturability at highvolumes. • Development of packaging and test solutions that are scalable, automated, andcompatible with co-packaged optics and advanced photonic-electronic integration. • Integration of heterogeneous materials and components, such as on-chip lasers,modulators, and detectors, using advanced packaging and assembly approaches. • Design-process-equipment co-optimisation, enabling repeatable, cost-effectiveproduction of complex photonic circuits and systems, including use of PDKs andvalidated building blocks. • Demonstration of system-level functionality through application-relevant use casesin strategic sectors (e.g. AI, sensing, telecommunication, mobility, health, defence),with quantified performance metrics and clear market relevance.

Expected Outcome: the proposals under this call are expected to address one or more of the following subjects : • Enhanced personalized monitoring, care and treatments, focusing on the development of highly customized healthcare solutions, including the required research and diagnostic tools, tailored to individual needs, covering various scenarios such as chronic disease management, physiotherapy, precision diagnosis, personalized medicine/treatment, pre- and postoperative care, and daily assistance in homes and common spaces. It also targets effective management of chronic diseases and elderly care through personalized monitoring and interventions facilitated by advanced sensor technologies and edge-to-cloud solutions. This includes the development and integration of solutions for Hospitalization at Home, enabling patients to receive complex, remotely supervised care using intelligent medical devices capable of sensing, analysing, and transmitting real-time data. This requires a continuum, from in-hospital diagnostics to robust, long-term patient support at home via AI-driven care pathways and hospitalization at home. • Prevention and treatment of diseases, allowing the improved…

Poland – Pharmaceutical products – Dostawa produktów leczniczych wykorzystywanych przez oddziały szpitala, leki stosowane w ramach programów lekowych oraz chemioterapii (część 1)

Sweden – Personal care products – Extern Remiss Hygien och städmaterial 2025

Provision of Non-Emergency Patient Transport Services (NEPTS) for GHFT. Additional information: GHFT (Gloucestershire Hospitals NHS Foundation Trust) "the Authority" invites Bidders to compete for the Provision of Non-Emergency Patient Transport Services (NEPTS) for GHFT. This procurement is being undertaken Provider Selection Regime which came into force on 1 January 2024. This Tender is only open all suppliers The Tender information can be found on the Trusts e-Portal (Atamis Health Family) at https://health-family.force.com/s/Welcome. Reference - C457853 You must be registered on the Atamis to view the Documents and all bids and communications must be submitted via this e-Portal. If you require any technical assistance using Atamis, please refer to the Supplier Portal user guide ( https://services.atamis.co.uk/docs/Supplier_User_Guide.pdf ) and/or the helpdesk on 0800 0988 201.

Italy – Miscellaneous medical devices and products – Fornitura di dispositivi sterili in TNT (teli, camici e kit) per uso chirurgico e dispositivi medici in TNT ed accessori a corredo di kit chirurgici in TTR

Spain – Welfare services for children and young people – CONTRATACIÓN DE 74 PLAZAS DE ACOGIMIENTO RESIDENCIAL MENORES. MODALIDAD: VARIAS

Italy – Social work services – SUA PROV BG. PREFETTURA DI BG. SERVIZIO ACCOGLIENZA E ASSISTENZA CITTADINI STRANIERI RICHIEDENTI PROTEZIONE INTERNAZIONALE C/O CENTRI ART.11 D.LGS. 142/2015 UBICATI NEL TERRITORIO PROVINCIALE DI BG - SINGOLE UNITA' ABITATIVE CON CAPACITA' RICETTIVA MAX 50 POSTI PER STRUTTURA - TOTALE COMPLESSIVO DI N. 150 POSTI, PER LA DURATA TRIENNALE, INIZIO PRESUNTO DALLA DATA DI STIPULA.

Expected Impact: The action under this topic is expected to achieve the following impacts and contribute to the following EU policies/initiatives: deliver innovative, early technology solutions that contribute to addressing strategic unmet public health needs across multiple therapy areas to improve prevention, early diagnosis, and treatment; leverage the unique network and scale of IHI JU members to create a pipeline to support innovative startups in the health industry, fully integrated into European initiatives in support of start-ups and entrepreneurship; drive early cross-sector health R&D and innovation to strengthen the European healthcare industry’s global competitiveness, contributing to the EU Industrial Strategy and Pharmaceutical Strategy objectives; create a sustainable network of European healthcare incubators to guide and support highly talented and innovative early-stage companies; harness digital health and data-sharing technologies (e.g., AI and big data) to enable interoperable health solutions, contributing to the European Health Data Space (EHDS) and improved evidence based care;- the action should generate a portfolio of early‑stage companies that have…

Expected Impact: The action under this topic is expected to achieve the following impacts: Faster and more informed decision-making through the use of an AI-driven NAM (AI Foundation Toxicology Model) and increased efficiency through rapid processing of vast amounts of data [1] . Increased consistency and standardisation in a NAM-based approach, specifically an AI model, used by industry in the efficient development, testing and production of safe and effective innovative health technologies, improving industrial competitiveness. Regulatory adoption of a NAM-enabled second species waiver model (AI Foundation Toxicology Model) and weight-of-evidence framework, in line with recommendations and more consistent global decision-making on waiving second species testing. Reduction in animal use, accelerated timelines and lower costs, enhancing the competitiveness of the European health industry through economical and ethical benefits. Improved public health as patients will benefit from safe and effective medicines developed faster using validated NAMs. The action is expected to contribute to the EU Directive (2010/63/EU) [2] on the protection of animals used for scientific purposes and…

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…

Expected Outcome: Project results are expected to contribute to all the following expected outcomes: Advance in the achievement of the Strategic Energy Technology (SET) Plan’s research and innovation priorities and targets for wind energy; Efficient and effective support to wind energy research and innovation through alignment and cooperation among different actors, avoiding fragmentation of efforts; Energy producers and consumers benefit from increased performance of wind energy technologies with the focus on efficiency and flexibility, reduced cost, improved reliability and sustainability, operation and maintenance, safety, robustness and security during all stages of the lifetime of a wind energy farm from installation, operation and maintenance to decommissioning; Increased contribution of wind energy to the energy system, with minimal impacts on health and the environment (notably biodiversity and pollution) and at the lowest possible cost. Scope: The action contributes to address the Strategic Energy Technology (SET) Plan’s research and innovation priorities and targets for wind energy, as defined by the Implementation Working Group (IWG) on wind energy, the European…

Sweden – Health and social work services – Drift av Vårdbostäderna Ekollongatan och Skräddaregården

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Increased evidence of factors such as physiological, behavioural, social, environmental and cultural that influence how different user and demographic groups perceive and use smart, secured, integrated energy efficient building systems, and how it affects the building whole-life cycle and energy savings, as well as occupant satisfaction, health and well-being; The design and operation of smart building systems and smart buildings are improved making them more user-friendly and effective. Scope: Significant investments have been made in developing hardware and software for smart buildings. There is still limited understanding how smart buildings solutions impact the energy performance of buildings and users’ comfort in practice. Research is required on the technical, social, and economic factors that influence how different groups – defined by their social, educational, age, and financial status – use and interact with smart buildings and systems. The whole-life cycle impacts of smart building have to be better understood, from design and construction to operation, maintenance,…

Bulgaria – Medical equipments – Доставка, монтаж, въвеждане в експлоатация, обучение и гаранционен сервиз на медицинска апаратура по обособени позиции

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Implementation of the NWRSA methodology for secondary rural roads; Innovative and effective enforcement strategies, incentive mechanisms and measures raising risk awareness for fostering safer behaviour; Prevention strategies for reducing road fatalities and serious road traffic injuries on rural roads along with the respective implementation guidelines and policy measures tailored to the responsible stakeholders (regional authorities, police, healthcare professionals, national governments, etc.); GIS-based application to assist local and regional authorities in identifying and mapping the impact of extreme weather phenomena and other natural disasters (such as floods, fires, storms, heavy snowfall etc.) on the safety and resilience of the road network in their jurisdiction. Scope: With more than 50% of all EU road fatalities occurring in rural areas along with evidence suggesting that crashes and crash-related fatalities in rural roads vary from those in urban roads or motorways, it is imperative to understand and mitigate the safety risks in rural roads in view of the EU’s…

Expected Outcome: Successful proposals will contribute to the implementation of the EU initiative on Biotechnology and Biomanufacturing and the EU Life Sciences Strategy as well as the updated EU Bioeconomy Strategy, the upcoming EU Biotechnology Act and EU Circular Economy Act. Projects’ results are expected to contribute to the following expected outcomes: Full industrial scale biorefinery and related value chain(s) for the production of nutritional food ingredients. Resilience and strategic autonomy of EU food sectors via diversification of nutritional food ingredient sources. Increased environmental sustainability of food sectors (e.g. addressing issues like land use, water use, energy consumption, nitrogen cycle, other nutrients, etc.). Improved consumers awareness and acceptance of nutritional food ingredients from alternative sources, contributing to sustainable healthy diets. Scope: Human nutrition is a key area where the bio-based industries can play an important role in addressing the present societal and climate challenges. Considerable attention is given to the utilisation of alternative sources of proteins, fibres and oils/fats, due to the increasing world population…

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Better understanding of the factors and interdependencies that influence levels of renovation of rental properties in the affordable housing sector; Increased number of policy makers revise policies, regulations, instruments and business models to increase the rate of renovation of rental properties in the affordable housing sector. Scope: The Renovation Wave strategy sets out measures across the whole renovation chain that aim to increase the rate and depth of renovations. One of the key principles for housing renovation towards 2030 and 2050 is affordability, i.e. making energy efficient, comfortable, healthy, sustainable and climate-resilient buildings widely available, in particular for medium and lower-income households and vulnerable people and areas. A better understanding of the impact of current policy frameworks on the affordable housing sector and on energy poverty is needed. Proposals are expected to address all of the following: Research the effectiveness and implications of existing policies at different levels of governance (from local to European), regulations,…

Czechia – Magnetic resonance unit – Magnetická rezonance

Expected Outcome: Projects should contribute to all of the following expected outcomes: Provide policymakers, education practitioners and citizens with a solid understanding of how social media, video gaming and other leisure uses of digital tools relate to the educational outcomes of young people, including through their impact on well-being and mental health. Generate rigorous, policy-relevant evidence about policies and practices aiming to inform and regulate young people’s use of digital tools for non-educational purposes, such as smartphones, at school. Develop actionable advice for policymakers and citizens about how to promote young people’s healthy use of digital tools for leisure, both at school and outside school. Describe and quantify the relationships of using digital tools for leisure and communication with students’ motivation, study habits, attention span and concentration, time management, engagement, social integration and overall well-being. Scope: The increasing prevalence of digital devices in young people’s life has raised concerns about the potential impacts of the use of digital tools for leisure and communication on primary-, secondary- and higher education…

Italy – Medical equipments – ACP3597PA - Fornitura in noleggio di macchine maceratrici (tritapadelle) con acquisto di materiale di consumo

Expected Outcome: Projects should contribute to all of the following expected outcomes: Evaluate the effectiveness and resilience of existing long term-care (LTC) policies at national and regional levels. Provide policy makers with scientific knowledge and data for evidence-informed policies to address the rising demand for affordable, accessible and high-quality long-term care, with the focus on efficient use of resources, including human, financial and technological. Propose new policy solutions to address rising long-term care needs and to ensure smooth (in)formal care transitions, including from the perspective of active and healthy ageing policies and the development of integrated care service provision at local level. Scope: In the EU, the number of people with long-term care needs is projected to increase in the future. In 2070, this number is expected to be 21% higher than in 2020.This increase is largely due to the acceleration of population ageing and also relates to higher needs for palliative care. At the same time, many Member States already struggle to meet all the long-term care needs now due to workforce shortages, which are likely to aggravate in future as the…

Expected Outcome: Projects should contribute to all of the following expected outcomes: Reinforced digital transformation of the news media industry by facilitating the development of new business models, contributing to a more resilient and inclusive democracies. Citizens, particularly those facing systemic disadvantages, are empowered and better equipped to make informed decisions, and news media’s role as contributor to a healthy, reinvigorated and fair democracy is enhanced. Stronger engagement with emerging media creators (such as influencers and other online content producers) to promote transparency and accountability in their role in sharing information, and to foster reliance on trustworthy media sources. Scope: Democracies are at risk when reliable and independent journalism is at risk. Yet, in order to be truly independent, media need sustainable financing models. At present, journalistic newsrooms are under severe economic pressure. Social media forces them to compete for citizens’ attention with other forms of infotainment, which sometimes entail unverified opinions and low-quality or malicious sources. To promote a well-informed democratic debate, citizens must be…

Expected Outcome: Projects should contribute to all of the following expected outcomes: Policymakers, educators, and other relevant actors have tools and recommendations to put in place more opportunities for lifelong civic and citizenship [1] learning, in support of democracy and democratic participation, including by relying on the opportunities offered by digital means, notably civic tech. Policymakers at local, regional, national and EU level have tools and recommendations for ensuring the participation of citizens in democratic life, whatever their background, especially those who face barriers to participation in democratic processes. Scope: A healthy democracy relies on citizens being able to make informed democratic choices, in free and fair elections. Meaningful and inclusive citizens’ participation and engagement can further complement and reinforce representative democracies and foster trust in public institutions. Education plays a major role in supporting active interest in democratic participation and citizen engagement. Accessible education in matters of democracy and participation in public-policy making is a lifelong process that concerns all age groups in society…

Expected Outcome: Projects should contribute to either the first and second (combined), or the third and fourth (combined) of the following expected outcomes: Improved implementation of the EU Pact on Migration and Asylum through evidence-based insights in asylum and migration management, age assessment of minors, and resettlement frameworks, ensuring fair and efficient migration governance. Insight into legal pathways addressing both EU Member States’ needs and potential offers of circular and permanent migration schemes in selected partner countries. Enhanced health equity for migrants, including refugees by integrating robust health data into national systems, addressing governance barriers, and tackling intersectional inequities in healthcare access, identifying data/indicators on basic needs in health and sanitation, including as compared to adequate treatment. Comprehensive evaluation of long-term social inclusion and integration strategies, providing evidence-based policy recommendations for labour market access, housing, education, health (including mental health), recognition of qualifications and validation of skills, youth participation, and social, political, and…

Estonia – Reagents and contrast media – Hematoloogia analüsaatori reaktiivid

Portugal – Pharmaceutical products – CI/1008/2026 Aquisição de Gases Medicinais, para a ULSTMAD, EPE.

Czechia – Analgesics – Fremanezumab

France – Medical consumables – Fourniture de DM DIVERS à usage unique pour la pharmacie du Centre Hospitalier Pierre Oudot à Bourgoin-Jallieu

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Romania – Laboratory reagents – PACHET REACTIVI DE LABORATOR compatibili cu analizorul VITROS 7600XT

Malta – Medical equipments, pharmaceuticals and personal care products – CT2154/2026 - TENDER FOR THE SUPPLY OF QTY 2 INTRA-OPERATIVE NERVE MONITORING SYSTEMS (ON LEASE) AND CONSUMABLES ON A PAY-PER-USE BASIS FOR ENT AND GENERAL SURGERY AT THE OPERATING THEATRE DEPARTMENT AT MATER DEI HOSPITAL

Netherlands – Social work and related services – Schuldhulpverlening voor (ex-)ondernemers

Spain – Patient-monitoring system – SUMINISTRO, INSTALACIÓN Y PUESTA EN FUNCIONAMIENTO DE UN SISTEMA DE MONITORIZACIÓN DE PACIENTE PARA LA FASE III DEL PLAN DIRECTOR DEL HOSPITAL CLÍNICO SAN CARLOS

The Council is procuring an Appropriate Adult Service as is required under Police and Criminal Evidence Act 1984 (PACE) and Crime and Disorder Act 1998, section 38(4)(a) which place a statutory duty on local authorities to provide Appropriate Adults for young people and vulnerable adults when a parent/guardian or other suitable adult is not available or appropriate.

Italy – Social services – PROCEDURA APERTA EX ART. 71 DEL D.LGS. 36/2023 PER IL SERVIZIO SOSTITUTIVO MENSA, MEDIANTE L’UTILIZZO DI BUONI PASTO ELETTRONICI E DEL SERVIZIO PER ACQUISTI DIGITALI NELL’AMBITO DEL PIANO DI WELFARE D

Romania – Medical equipments – Achiziționare echipamente medicale în cadrul Proiectului: ”Tehnologie Avansată pentru Inimi în Luptă la Spitalul Clinic Județean de Urgență Arad” (3 loturi)

Nottinghamshire County Council (the Council) is seeking to commission an experienced Provider for the delivery of an outcome focussed, high quality and child-centred Child Sexual Exploitation (CSE) and Child Criminal Exploitation (CCE) support service, which will include support for care leavers up to the age of 25. The Council is seeking bids that offer value for money through efficiency and innovative thinking, and Bidders will be required to identify the level of service (hours) that will be provided for the funds available. Nottinghamshire County Council wishes to appoint a single service provider. The scope and nature of the services required by the Council are set out in more detail in the Specification.

Bulgaria – Pharmaceutical products – „Доставка на лекарства, медицински консумативи и изделия и лекарствените продукти, включени в Списък III - Рискови вещества, Приложение №3 към чл.3, т.3 от „Наредба за реда за класифициране на растенията и веществата, като наркотични“ приета с ПМС №293 от 27.10.2011 г., за нуждите на Община Варна и второстепенните разпоредители с бюджет по обособени позиции“

Romania – Medical equipments – Furnizare echipamente medicale, echipamente specifice, echipamente IT și sisteme software aferente obiectivului de investiție „Centru integrat de îngrijiri paliative în județul Galați”

Provision of Allograft Products to Queen Victoria Hospital NHS Foundation Trust Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk

Czechia – Medical consumables – Dodávky dialyzačních roztoků a spotřebního materiálu k přístroji multiFiltrate (PRO) a multifiltrate CiCa

This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Both structural and functional aspects, including visualizing dynamic elements are important to development of new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Ultimately, research supported in response to this RFA is to encourage technologies that allow, for example, structures such as hair cells, otoliths, membranes, ions, and vasculature to be viewed in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multi-disciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans and intermediate studies in animals, but not non-mammalian species, may be proposed to develop or advance the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.

Dunraven Educational Trust requires one supplier to fulfil their SEMH Services provision at Rosendale Primary School. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18147. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18147 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Expected Outcome: Project results are expected to contribute to some or all of the following outcomes: Critical infrastructure operators and authorities have access to efficient, adaptable, resilient and reliable tools and processes enabling or improving virtual and physical stress tests of their respective assets/ and operations; Critical entities have broader and deeper understanding of their technical and operational vulnerabilities and adaptive capabilities, improving the scenario building and stress tests exercises; Systems allowing notification and collaboration under stress conditions are available for relevant stakeholders; Critical entities are better equipped for post-incident investigations, including data collection, analysis and improved learning, management and sharing in a secure manner; Improved operational procedures including incidents management and training curricula are developed. Scope: The resilience of critical entities is of paramount importance as disruptions to these systems can have significant consequences for the whole economy, public health, security or safety. These systems, responsible for providing essential services for modern society, are…

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NIDCD R25 program is to support educational activities that help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences.

This Notice of Funding Opportunity (NOFO) invites eligible academic or research institutions to apply for funding support to purchase latest scientific equipment that will enhance and modernize research-supporting operations of existing shared biomedical research facilities. Targeted are laboratory research core facilities, animal research facilities, and other similar shared-use research spaces. The goal of this NOFO is to strengthen research-auxiliary activities of biomedical research facilities and to enhance the efficiency of their operations. The NOFO does not support the purchase of scientific research instruments or their components, nor components of building-level infrastructure equipment that indirectly support research activities.

This funding opportunity aims to support high risk clinical trials for the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Structural and functional aspects, including visualizing dynamic elements, are important to developing new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Research supported in response to this RFA is expected to significantly advance the ability to visualize auditory and vestibular components, such as hair cells, otoliths, membranes, ions, and vasculature, in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multidisciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans must be proposed to develop,advance, or test the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.

Czechia – Diagnostic devices – Zajištění diagnostik pro imunoanalytické stanovení autoprotilátek - UKIA

Romania – Tomography devices – Achiziție computer tomograf

Bulgaria – Medical equipments, pharmaceuticals and personal care products – „Доставка на стъклария, химикали, реактиви, консумативи и други за нуждите на звената на Медицински университет – София по 35 обособени позиции”

Spain – Medical equipments – Contrato de Suministro (CONTR 2026 0000232975)

Finland – Pharmacy services – Lääkkeiden koneellinen annosjakelu

Czechia – Medical consumables – Spotřební materiál pro hematologické analyzátory včetně výpůjčky

Expected Outcome: Project results are expected to contribute to some or all of the following expected outcomes: Creation of cutting-edge tools, processes, equipment and technologies to enhance disaster and emergency response capabilities for various practitioners as well as for assets, such as vehicles, aircraft, and heavy equipment; Taking into consideration existing technologies, development of autonomous drones, robotics, and other technologies specifically designed for emergency medical response and search and rescue operations in hazardous conditions such as wildfires, earthquakes and large-scale events; Improvement of response efficiency and safety for survivors and emergency practitioners through the adoption of advanced, technology-driven solutions in disaster scenarios; Consider needs of existing EU-level capacities, emergency reserves, and stockpiling in the deployment of the assets and being able to move them. Scope: The scope of this topic is the development of innovative tools, equipment, and technologies to enhance the capabilities of emergency responders operating in complex and hazardous disaster environments. By leveraging advancements in smart protective…

Liverpool City Council, through Liverpool Virtual School, is seeking a provider to deliver a psychology-informed workforce development and consultation service that supports children in care, previously looked-after children, and children with a social worker. The service will provide trauma-informed and attachment-aware consultation, training, reflective supervision, and strategic leadership support to schools, social care professionals, carers, and Virtual School staff. The focus is on improving educational planning, inclusive practice, workforce capability, and multi-agency collaboration through psychologically informed approaches that strengthen understanding of children's needs, behaviour, wellbeing and engagement in learning. The service is educational rather than clinical, and no therapy, diagnosis or treatment is required under the contract. The contract is valued at £75,600 per annum, with an initial term of 3 years and an option to extend for a further 12 months, giving a potential total contract value of up to £302,400 (inclusive of the extension period). Delivery will comprise approximately 88 days per year over an 11-month period.

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Housing-led approaches [1] aligned with the NEB are made available to stakeholders involved in tackling homelessness [1] . Robust evidence on NEB-aligned housing-led approaches tackling homelessness (including people temporarily hosted by acquaintances and family) to inform the development and/or update of policies and services for prevention and early intervention in the context of the green transition [1] in neighbourhoods [1] . Scope: Social and affordable housing is being advanced in the EU, including through the Affordable Housing Initiative [5] . Despite efforts, current policies for the green transition are failing to adequately address the housing crisis. Homelessness remains a structural challenge across Europe, with negative impacts on both individuals experiencing it (e.g. physical and mental health, social and economic conditions) and neighbourhood communities [1] (e.g. pressure on public services, erosion of social fabric [1] , etc.). Research and innovation gaps in tackling homelessness range from data collection (i.e. the variety of approaches to defining,…

Czechia – Artificial joints – Individuální onkologické implantáty

Czechia – Beds for medical use – Nákup 42 ks lůžek s laterálním náklonem, 81 ks lůžek polohovacích a 120 ks nočních stolků

North Macedonia – Medical equipments, pharmaceuticals and personal care products – EVAR AND TEVAR

Portugal – Medical equipments – 12025426 - FORNECIMENTO DE LENTES INTRAOCULARES E OUTRO MATERIAL DE OFTALMOLOGIA, DESTINADAS À UNIDADE LOCAL DE SAÚDE DE SÃO JOSÉ, EPE, PARA 2026

Malta – Medicinal products used in diabetes – CT2181/2026 - Framework Contract for the supply of Fulvestrant 250mg solution for injection

NIGMS will support innovative educational activities designed to equip participants with technical, operational, or professional skills required for careers in the biomedical research workforce. Activities must be open to the broader biomedical research community and may focus on participants at one or more career stages from undergraduates to professionals (for example faculty, staff scientists). Funded programs will have a robust program leadership structure, participant recruitment plan, and evaluation and dissemination plans.

Spain – Personal care products – Suministro de productos para la higiene personal para los usuarios de centros dependientes del IAS.

France – Medical consumables – Fournitures de laboratoires : Anticorps et produits associés (9 lots)

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Robust evidence on how inhabitants experience their neighbourhood [1] and the impact of these experiences on their health and well-being. The research informs policies, strategies, neighbourhood planning and procurement for the green transition [1] of neighbourhoods, including their nature-positive [3] transformation and climate resilience. Scope: Neighbourhoods are human-social constructs and environments. They are shaped by complex inter-connections and interdependencies of human and non-human actors in the natural and built environment [1] they comprise. An increasing body of research is looking at the relationship between people and the built environment, from neuro-architectural aspects of space to atmosphere and ambiance aspects in urban design and planning, influencing also the perception of beauty. Digitalisation is also allowing to understand, map and enhance how inhabitants experience the built environment. Yet, more evidence is needed on how inhabitants react to and identify with their neighbourhoods as well as the effects of these experiences on their physical and…

This announcement invites applications for basic research projects on chemical warfare agents, toxic industrial chemicals, and pesticides that have primary or secondary effects on the nervous system. Chemical threats are toxic compounds that could be used in a terrorist attack or accidentally released from industrial production, storage, or shipping. Projects supported by this NOFO are expected to generate data that elucidate mechanisms of toxicity of these agents, possible new manifestations of toxic exposures, and potential new targets for therapeutic development.

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Significantly higher awareness of the construction ecosystem actors about solutions that are inspired by vernacular knowledge [1] , nature-based solutions [1] , bioclimatic design and/or frugal innovation [1] . The application of the developed solutions helps to achieve and maintain the thermal comfort in buildings while significantly reducing life cycle energy use, GHG emissions and costs compared to solutions that currently dominate the market. Scope: Reducing life cycle GHG emissions in buildings is key to meet the Green Deal’s objectives and make the built environment more sustainable [1] . However, achieving thermal comfort inside buildings with poor thermal resilience often relies on energy-intensive solutions, such as air conditioning which not only emits GHGs and represents significant energy costs, but also contributes to urban heat island effects, impacting the health and well-being in neighbourhoods [1] , particularly for groups in a vulnerable situation such as the elderly and low-income households. There is therefore a need to further develop and demonstrate the…

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Evidence of the structural social infrastructure [1] and services needed to address homelessness [1] at neighbourhood [1] level is made available to stakeholders involved in tackling homelessness. Improved availability and accessibility of key social infrastructure and services for homeless groups in the targeted neighbourhoods. Scope: Based on 2024 data, over 1.2 million people are estimated to experience homelessness in Europe [4] , with a significant proportion (45%) of surveyed homeless individuals finding themselves in a situation of chronic homelessness for over two years [5] . While housing-led approaches [1] are crucial to tackle homelessness, addressing the structural and multidimensional causes of homelessness also requires systemic interventions focusing on social infrastructure and services in neighbourhoods. Social infrastructure and services include the physical places as well as public and community [1] sector facilities and services that support and enable access to healthcare, employment, education, community integration, and other social services. They must be…

This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research priority. Applications submitted under this NOFO are expected to propose a multisite feasibility clinical trial that will provide new information that is scientifically necessary for the planning and conduct of a subsequent clinical efficacy or effectiveness study, pragmatic trial, or dissemination and implementation trial within NCCIHs mission. NCCIH expects that applications to this NOFO will describe the planned future clinical trial and in so doing demonstrate that the proposed (R01) research is scientifically necessary to design or plan the subsequent fully powered, full-scale clinical trial. Under this R01, the data collected should be used to fill gaps in scientific knowledge, including, but not limited to the following: assessing whether the intervention can be delivered with fidelity across sites; demonstrating feasibility of recruitment, accrual, and randomization of participants across sites; demonstrating participant adherence to the intervention, as well as retention of participants throughout the study across sites; refining and assessing the feasibility of protocolized multimodal interventions, and/or demonstrating feasibility of data collection across sites in preparation for a future fully powered, multisite efficacy or effectiveness trial. The need for multisite feasibility trials is expected to be justified by sufficient preliminary data from previous single site feasibility or acceptability trial(s) or the published literature. The data collected should be used to fill gaps in scientific knowledge and be necessary to develop a competitive fully powered multisite clinical trial that has the potential to make a significant impact on public health.

Lithuania – Various medicinal products – Medikamentai gyvūnų gydymui_

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will provide up to three years (R61 phase) of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural products effect (i.e., measure of mechanism of action) when used by humans on a specified target measure. If milestones in the R61 phase are achieved, up to 3 years of additional support (R33 phase) may be awarded to replicate the impact of the natural product on target engagement(s) when used by humans and assess whether there is an association between the degree of the impact on the target engagement and clinical outcomes in a participant population. Applications are encouraged to design R33 studies to determine how to optimize the impact of the natural product on the target engagement by optimizing the delivery of the natural product through examination of different doses or formulations. In addition, applications can be designed to combine the natural product with another treatment approach that is known to impact the same target engagement measure; or study the impact of the natural product in a population that is more responsive,

Objective: 1. Background The EDCTP Prizes 2026-2027 are recognition prizes funded under Horizon Europe. Prizes are financial contributions given as rewards following the publication of a contest. A ‘recognition prize’ is used to recognise past achievements and outstanding work after it has been performed, whereas an ‘inducement prize’ is used to spur investment in a given direction, by specifying a target prior to the performance of the work. Applications will have to clearly state the involvement of the applicants in the research and innovation activities within the remit of the Global Health EDCTP3 programme. Applicants will have to provide proof of eligibility and a written presentation of the achievements, which will be presented to an independent panel of experts for evaluation. The amounts of the prizes are specified in section 3. They are not linked to the costs incurred by the winner. 2. EDCTP3 Prizes 2026 and related award criteria The prizes will be awarded to the entry that, in the opinion of the independent expert jury, demonstrates having best addressed the cumulative criteria specified under the respective descriptions below. Applications will be graded on a total of…

The purpose of this initiative is to: (1) support the efforts by R15-eligible Principal Investigators (PIs) to conduct rigorous basic and/or mechanistic pain research projects; (2) promote integrated, interdisciplinary research partnerships between R15-eligible PIs and additional investigators from U.S. domestic institutions, and (3) enhance the pain research environment at the R15-eligible institution for health professional trainees or undergraduate and/or graduate students by actively engaging them in the proposed pain research projects.

The Life Sciences Transformational R&D Investment Fund Pilot offers capital grants to support large-scale R&D projects in the UK life sciences sector (eligible projects must exceed £100 million in total costs). It aims to boost research and development within the UK's Life Sciences sector by supporting large-scale investments focused on innovation and strengthening health resilience, as well as projects with the potential to generate economic benefits. This fund complements the separate Life Sciences Innovative Manufacturing Fund (LSIMF).

The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applicants applying for funding under this NOFO should be ready to initiate the clinical trial within the first quarter of the project period. Discussion, submission, and attainment of applicable regulatory (FDA, DSMB, IRB) approvals, and establishment of drug (and placebo, if applicable) supplies, and any necessary third-party agreements should be established by the time of award. If time and support for these and other pre-clinical and/or trial readiness activities are desired, applicants should consider the companion NOFO which utilizes an R61/R33 phased approach.

UK registered businesses can apply for funding for life science manufacturing capital investment projects which help increase UK health resilience.

Objective: 1. Background The EDCTP Prizes 2026-2027 are recognition prizes funded under Horizon Europe. Prizes are financial contributions given as rewards following the publication of a contest. A ‘recognition prize’ is used to recognise past achievements and outstanding work after it has been performed, whereas an ‘inducement prize’ is used to spur investment in a given direction, by specifying a target prior to the performance of the work. Applications will have to clearly state the involvement of the applicants in the research and innovation activities within the remit of the Global Health EDCTP3 programme. Applicants will have to provide proof of eligibility and a written presentation of the achievements, which will be presented to an independent panel of experts for evaluation. The amounts of the prizes are specified in section 3. They are not linked to the costs incurred by the winner. 2. EDCTP3 Prizes 2026 and related award criteria The prizes will be awarded to the entry that, in the opinion of the independent expert jury, demonstrates having best addressed the cumulative criteria specified under the respective descriptions below. Applications will be graded on a total of…

The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for Education and Research Centers (ERCs) that are focused on occupational safety and health training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the primary means for meeting this mandate. ERCs are academic institutions that provide high-quality interdisciplinary graduate and post-graduate training, research training, continuing education, and outreach in the core occupational safety and health disciplines of industrial hygiene, occupational health nursing, occupational medicine, and occupational safety, as well as allied disciplines. Research and research training are integral components of ERCs, with ERC faculty and NIOSH trainees conducting research on issues related to the NIOSH National Occupational Research Agenda (NORA) and emerging issues to advance the field of occupational safety and health. NIOSH ERCs have regional presence to further diversify the occupational safety and health profession through their core values, mission statements, and outputs. ERCs serve as resources for our nation's workforce through continuing education, outreach and strong collaboration with professional associations, worker advocacy groups, businesses, industries, and public health agencies. ERCs work with other institutions and organizations, including Minority Serving Institutions and other NIOSH supported training programs to have a positive impact on worker health, safety, and well-being.

CDC seeks to enhance the nation’s ability to rapidly mobilize, surge, and respond to public health emergencies (PHEs) as identified by CDC by establishing a roster of approved but unfunded (ABU) applicants that may receive rapid funding to respond to PHEs of such magnitude, complexity, or significance that they would have an overwhelming impact upon, and exceed resources available to, the jurisdictions. Applicants will undergo an objective merit review process, and entities that successfully meet the requirements for approval will be placed on the ABU list. CDC will use this ABU list for emergencies that require federal support to effectively respond to, manage, and address identified public health threats. CDC will make funding related to this NOFO available once it has determined a public health emergency exists or is considered imminent and will be contingent upon the availability and stipulations of appropriations. CDC will provide additional guidance and information to those on the ABU list when this NOFO is funded. Since this NOFO is designed to collect applications prior to a PHE, applicants are encouraged to submit work plans and budgets that demonstrate their ability to respond to a PHE. COVID-19 public health response plans, such as plans funded under CDC-RFA-TP18-1802 in 2020 are acceptable for this purpose. If this NOFO is funded for a specific PHE, CDC will develop supplemental guidance that outlines additional work plan and budget requirements tailored to the emergency. This NOFO is not a capacity-building funding mechanism, and it is not intended to create or establish new public health (PH) emergency management programs. It may be used to re- establish capacity lost or diminished because of the public health crisis. It is designed to support the surge needs of existing programs responding to a significant PHE. CDC will provide supplemental guidance to entities on the ABU list when this NOFO is activated regarding specific activities intended to address the emergency. CDC has strong relationships with governmental PH departments, community-based organizations, and other domestic partners and supports them for planning, capacity-building, preparedness, and response to PHEs. This NOFO complements these ongoing capacity-building preparedness and response programs by providing a mechanism for CDC to rapidly mobilize and fund PH organizations for specific response needs. Applicants must describe how this funding will not duplicate or supplant other federal funding. Upon occurrence of a PHE, CDC can rapidly fund specific applicants to accelerate public health crisis response activities such as coordinating emergency operations, hiring surge staff, and conducting needs assessments to determine the resources necessary to address the public health crisis. The NOFO also provides funding for specialized public health emergency response activities tailored to the specific public health crisis.

The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.

Romania – Medical furniture – „Mobilier medical și echipamente auxiliare” prin - Autoritatea de Management pentru Programul Sanatate, pentru implementarea proiectului cu cod SMIS: 2021:353063 intitulat "“Controlul cancerului de col uterin prin Acces echitabil la servicii de calitate: consolidarea capacității programului național de screening – (CLARA)”

Objective: 1. Background The EDCTP Prizes 2026-2027 are recognition prizes funded under Horizon Europe. Prizes are financial contributions given as rewards following the publication of a contest. A ‘recognition prize’ is used to recognise past achievements and outstanding work after it has been performed, whereas an ‘inducement prize’ is used to spur investment in a given direction, by specifying a target prior to the performance of the work. Applications will have to clearly state the involvement of the applicants in the research and innovation activities within the remit of the Global Health EDCTP3 programme. Applicants will have to provide proof of eligibility and a written presentation of the achievements, which will be presented to an independent panel of experts for evaluation. The amounts of the prizes are specified in section 3. They are not linked to the costs incurred by the winner. 2. EDCTP3 Prizes 2026 and related award criteria The prizes will be awarded to the entry that, in the opinion of the independent expert jury, demonstrates having best addressed the cumulative criteria specified under the respective descriptions below. Applications will be graded on a total of…

The purpose of this NOFO is to enhance the capability of NCATS CTSA Program KL2 scholars and recipients of re-entry supplements supported by the CTSA Program to conduct research as they complete the transition to fully independent academic translational scientists. These R03 grants will support different clinical and translational science research projects, including pilot and feasibility studies; secondary data analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. Research proposed in the R03 application may or may not include patient-oriented research. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that provide preliminary data to support submission of a subsequent R01, or equivalent, application.

Objective: 1. Background The EDCTP Prizes 2026-2027 are recognition prizes funded under Horizon Europe. Prizes are financial contributions given as rewards following the publication of a contest. A ‘recognition prize’ is used to recognise past achievements and outstanding work after it has been performed, whereas an ‘inducement prize’ is used to spur investment in a given direction, by specifying a target prior to the performance of the work. Applications will have to clearly state the involvement of the applicants in the research and innovation activities within the remit of the Global Health EDCTP3 programme. Applicants will have to provide proof of eligibility and a written presentation of the achievements, which will be presented to an independent panel of experts for evaluation. The amounts of the prizes are specified in section 3. They are not linked to the costs incurred by the winner. 2. EDCTP3 Prizes 2026 and related award criteria The prizes will be awarded to the entry that, in the opinion of the independent expert jury, demonstrates having best addressed the cumulative criteria specified under the respective descriptions below. Applications will be graded on a total of…

Objective: 1. Background The EDCTP Prizes 2026-2027 are recognition prizes funded under Horizon Europe. Prizes are financial contributions given as rewards following the publication of a contest. A ‘recognition prize’ is used to recognise past achievements and outstanding work after it has been performed, whereas an ‘inducement prize’ is used to spur investment in a given direction, by specifying a target prior to the performance of the work. Applications will have to clearly state the involvement of the applicants in the research and innovation activities within the remit of the Global Health EDCTP3 programme. Applicants will have to provide proof of eligibility and a written presentation of the achievements, which will be presented to an independent panel of experts for evaluation. The amounts of the prizes are specified in section 3. They are not linked to the costs incurred by the winner. 2. EDCTP3 Prizes 2026 and related award criteria The prizes will be awarded to the entry that, in the opinion of the independent expert jury, demonstrates having best addressed the cumulative criteria specified under the respective descriptions below. Applications will be graded on a total of…

Objective: 1. Background The EDCTP Prizes 2026-2027 are recognition prizes funded under Horizon Europe. Prizes are financial contributions given as rewards following the publication of a contest. A ‘recognition prize’ is used to recognise past achievements and outstanding work after it has been performed, whereas an ‘inducement prize’ is used to spur investment in a given direction, by specifying a target prior to the performance of the work. Applications will have to clearly state the involvement of the applicants in the research and innovation activities within the remit of the Global Health EDCTP3 programme. Applicants will have to provide proof of eligibility and a written presentation of the achievements, which will be presented to an independent panel of experts for evaluation. The amounts of the prizes are specified in section 3. They are not linked to the costs incurred by the winner. 2. EDCTP3 Prizes 2026 and related award criteria The prizes will be awarded to the entry that, in the opinion of the independent expert jury, demonstrates having best addressed the cumulative criteria specified under the respective descriptions below. Applications will be graded on a total of…

The Tree Health Pilot (THP) scheme is testing different ways of slowing the spread of pests and diseases affecting trees in England. It expands on support available through the Countryside Stewardship Woodland Tree Health grant. The THP supports owners and managers of trees in woodland or trees outside woodland to deal with tree health issues. Funding from the pilot can go towards a range of measures including: felling and treating diseased or infested trees and necessary infrastructure improvements; restocking with new trees and capital items to assist this; maintenance of newly planted trees biosecurity items. he Tree Health Pilot guidance on GOV.UK sets out the aims of the pilot in detail including eligibility and application details.

The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities such as medicinal chemistry; pharmacokinetics (PK); Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET); efficacy in animal models; development of biomarkers for target engagement; formulation development; chemical synthesis under Good Manufacturing Practices (GMP); Investigational New Drug (IND) enabling studies; and initial Phase I clinical testing. Applications not responsive to this NOFO include research on basic mechanisms of disease or mechanisms of drug action; development ofrisk, diagnostic, prognostic, predictive, and preventionbiomarkers, devices, non-pharmacological interventions (e.g., exercise, diet, cognitive training), repurposed drugs and combination therapies; discovery activities such as high-throughput screening and hit optimization; and stand-alone clinical trials.

Romania – Medical equipments – Furnizare dotări și echipamente medicale pentru obiectivul de investiţie „Construire Corp nou - Departament Sănătatea mamei și copilului Spitalul Clinic Județean de Urgență Sf. Apostol Andrei Constanța”

Poland – Pharmaceutical products – Zakup i dostawa leków onkologicznych dla Apteki Szpitalnej Świętokrzyskiego Centrum Onkologii w Kielcach.

This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD.

The goal of the training grant program is to enhance the quality and availability of safety training for United States commercial fishermen. Availability includes the frequency, geographic considerations, channels or partners of dissemination, culturally and/or educational appropriate training material, and other characteristics of a successful training program. As a result, the Coast Guard and NIOSH invite applications to support the development and implementation of training and education programs that: develop and deliver training which addresses the needs of commercial fishermen in the United States provide qualified marine safety instructors, or otherwise accepted by the National Maritime Center instructors and faculty to conduct the training evaluate the effectiveness and impact of the training program on reducing injuries among fishermen coordinate with existing training programs and partnerships with industry fishermen, and agencies conform to 46 U.S.C. § 4502 (i) Safety Standards for commercial fishing safety training In order to support and administer the grant program, the Coast Guard and NIOSH signed a Memorandum of Understanding on May 17, 2018. While the Coast Guard, along with the Occupational Safety and Health Administration (OSHA), provides regulatory oversight for safety and health matters within the commercial fishing industry, NIOSH is an agency operating under the Centers for Disease Control and Prevention (CDC) with the mission of generating new knowledge in occupational safety and health and transferring that knowledge into practice to prevent worker injury, illness and death. NIOSH conducts and funds scientific research, develops methods to prevent occupational hazards, develops guidance and authoritative recommendations, translates scientific knowledge into products and services, disseminates information, identifies factors underlying work-related disease and injury and responds to requests for workplace health hazard evaluations.

Romania – Angiography supplies – Acord Cadru furnizare “CONSUMABILE MEDICALE PENTRU COMPARTIMENTUL DE ANGIOGRAFIE ”

Supply of Essential Vaccines to the National Immunisation Program

Spain – Surgical implants – SUMINISTRO SUCESIVO DE IMPLANTES DE COLUMNA

Finland – Medical practice services – Erikoislääkäripalveluiden ostopalveluhankinta / Toimittajarekisteri

Italy – Miscellaneous medical devices and products – Gara europea Dispositivi Endoscopia

Bulgaria – Vaccines – „Доставка на ваксини срещу варицела за извършване на задължителна имунизация и реимунизация и на ваксини срещу респираторно-синцитиален вирус за извършване на целева имунизация за 2026-2028 г.“

National Support Unit for the First Nations Maternal and Child Health Grants.

France – Medical equipments – EQUIPEMENTS DE NEONATATOLOGIE ET DE MATERNITE

Spain – Pharmaceutical products – AM SUMINISTRO MEDICAMENTOS C (CCA. +6.C92WEGQ) SIGLO. 366/2024

Italy – Diagnostic systems – Gara a Procedura Aperta telematica per la fornitura in service di “Sistemi Diagnostici di Laboratorio e Microbiologia” per l’Azienda Ulss 2 Marca trevigiana, per il periodo di 84 mesi.

Poland – Various medicinal products – Dostawa leków stosowanych w programach lekowych.

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage UG3/UH3 phased cooperative agreement research applications to plan and implement behavioral and social intervention clinical trials. Studies appropriate for this announcement include clinical trials to develop and test behavior change interventions related to dental, oral, or craniofacial conditions. Awards made under this FOA will initially support a milestone-driven planning phase (UG3) for up to 2 years, with possible transition to a clinical trial implementation phase (UH3) of up to five years. Only UG3 projects that have met the scientific milestones and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The UG3 phase will permit both scientific and operational planning activities. Scientific planning activities include small-scale data collection to assess the feasibility and/or acceptability of a planned behavioral or social intervention and associated study procedures (e.g., acceptability of study content or mode of delivery; feasibility of proposed data collection procedures; preliminary testing of intervention training and fidelity monitoring procedures). Operational planning activities include, at a minimum, development of: the final clinical protocol; the intervention manual or equivalent; the data management system and other tools for data and quality management, safety and operational oversight plans; recruitment and retention strategies; and other essential documents. The UH3 phase will support the conduct of investigator-initiated intervention research at all stages, from early mechanistic research and intervention development (e.g., Stages 0/ I) through implementation and cost-effectiveness research (Stages IV/V).

Romania – Laboratory reagents – Acord-cadru Reactivi de Laborator

Czechia – Antineoplastic and immunomodulating agents – Dodávky léčivých přípravků s účinnou látkou OFATUMUMAB 2026

This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact.

This Notice of Funding Opportunity Announcement (NOFO) invites R25 applications to support the development and implementation of research education programs for recent baccalaureates from all backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences. It is essential to expand and broaden the skilled Alzheimers Disease (AD) and Alzheimers Disease and Related Dementias (ADRD) research workforce and provide exposure to AD/ADRD research to individuals early in their careers. The proposed research education programs will support intensive research experiences in the AD/ADRD field with the goal of preparing recent baccalaureates to transition into strong, research-focused advanced degree programs or competitive private sector research careers in AD-related disciplines.

Romania – Medical equipments – Sistem Chirurgie Minim Invazivă Asistată Robotic

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences.

Spain – Vaccines – Vacuna antigripal trivalente inactivada de alta carga producida a partir de virus crecidos en huevos embrionados

Spain – Medical equipments, pharmaceuticals and personal care products – FARM F137-2026

Poland – Pharmaceutical products – Zakup i dostawa leków i wyrobów medycznych dla potrzeb Radomskiego Szpitala Specjalistycznego

Italy – Reagents and contrast media – P.A. INDAGINI IMMUNOISTOCHIMICHE

Netherlands – Renal support devices – Dialyseapparatuur (CRRT) inclusief disposables en vloeistoffen - gerectificeerd

Sweden – Dental and subspecialty instruments and devices – Dentalinredning

Spain – Ambulance services – Contratación del servicio de transporte de pacientes de los centros asistenciales de FREMAP, Mutua Colaboradora con la Seguridad Social nº61, en Madrid.

Reissue of RFA-20-351.The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications to pursue invasive neural recording studies focused on mental health-relevant questions. Invasive neural recordings provide an unparalleled window into the human brain to explore the neural circuitry and neural dynamics underlying complex moods, emotions, cognitive functions, and behaviors with high spatial and temporal resolution. Additionally, the ability to stimulate, via the same electrodes, allows for direct causal tests by modulating network dynamics. This funding opportunity aims to target a gap in the scientific knowledge of neural circuit function related to mental health disorders. Researchers should target specific questions suited to invasive recording modalities that have high translational potential. Development of new technologies and therapies are outside the scope of this NOFO.

Romania – Laboratory reagents – Achiziționare reactivi și consumabile de laborator (11 loturi)

The purpose of this Notice of Funding Announcement (NOFO) is to encourage pilot research that is not an immediate precursor to testing a service intervention but is consistent with NIMH priorities for services research. While NIMH now requires use of an experimental therapeutics model for all intervention studies, there is recognition that some mission-relevant areas of services research do not involve clinical trials.

This Notice of Funding Opportunity (NOFO) invites R25 applications to support the development and implementation of summer research education programs for high school students, undergraduates, or science teachers from all backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences. It is essential to expand and broaden the skilled Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) research workforce and provide exposure to AD/ADRD research to individuals early in their careers. The proposed research education programs will support intensive summer research experiences in the AD/ADRD field with the goal of exposing participants to AD/ADRD research and encourage further study or participation in biomedical and behavioral research. This NOFO does not allow participants to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

This notice of funding opportunity (NOFO) encourages innovative research to develop, improve, characterize, and preserve animal models as well as animal model related biological materials, technologies, and new approach methodologies (NAMs) for studies relevant to human health and disease. This NOFO also seeks projects aimed at improving the diagnosis and control of diseases that could confound or interfere with animal use in biomedical research. The proposed project must have broad applicability to multiple NIH Institutes or Centers (ICs) to align with the NIH-wide mission of the Office of Research Infrastructure Programs (ORIP). The proposed studies must include animal models and explore multiple body systems or multiple categories of diseases. Applications that develop models focused on a specific disease or area of research, or only propose studies primarily relevant to a single NIH IC, will be considered not acceptable to this NOFO and will be withdrawn.

Spain – Welfare services for children and young people – 579,580,581,582,583,584,585/2025 Servicios de intervención socioeducativa (SIS) para niños y adolescentes de 0 a 17 años

Romania – Pharmaceutical products – medicamente

Austria – Medical consumables – ENDO-RV-Gastro Stents in verschiedenen Größen

The NEI supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies on eye/vision conditions. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study rationale, design, analytic methods, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a study protocol and Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity. This clinical research planning grant funding opportunity supports applicants in their planning efforts to conduct collaborative clinical research. The grant may be used to support the development of a study protocol and MOP, as well as to conduct preliminary studies to refine study procedures or document recruitment potential. The grant must not be used to generate data on the effects of a proposed intervention. This NEI NOFO is applicable to both epidemiologic and clinical trial research studies.

Poland – Medical equipments – Upgrade rezonansu magnetycznego model Aera 1.5T, numer seryjny 141616 w celu realizacji projektu pn. Rozwój zdolności leczenia onkologicznego w SP ZOZ MSWiA w Lublinie poprzez utworzenie nowych oddziałów wraz z modernizacją bazy sprzętowej

The purpose of the NIAID Career Transition Award program is to assist postdoctoral fellows' transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist.

Romania – Medical equipments – Linie Automată de Prelucrare Preanalitică, Analitică şi Postanalitică a probelor biologice în Laborator

Romania – Dialysis solutions – MEDICAMENTE PROGRAME NATIONALE - SCLEROZA MULTIPLA, DIALIZA, HIV-SIDA, ONCOLOGIE , ATI

Poland – Fracture appliances, pins and plates – „Dostawa endoprotez i implantów do SP ZOZ Szpitala Wielospecjalistycznego w Jaworznie”

Independent Expert Assessments of Family Violence

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to elucidate a role for understudied proteins in rare disease. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s). A list of eligible proteins is provided and are members of druggable protein families that have a known association with a rare disease. This NOFO is intended to jumpstart research on understudied proteins that are associated with rare diseases and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the characterization of understudied proteins within the context of rare disease.

Spain – Orthopaedic implants – Suministro de Fijadores Externos para la OSI Ezkerraldea Enkarterri Cruces

Spain – Dental and subspecialty instruments and devices – Acuerdo marco para la homologación de suministro de material fungible y protésico para la Clínica Odontológica de la Universidad de Salamanca

Spain – Pharmaceutical products – JAEN CBAM SANOFI AVENTIS, S.A. AM 1229/2024

Poland – Adhesive dressings – Dostawa materiałów opatrunkowych dla Szpitala wraz z najmem aparatów do podciśnieniowego leczenia ran

This Notice of Funding Opportunity (NOFO) aims to support new biomedical, behavioral, and social science investigators who are in the early stages of establishing independent careers in tobacco regulatory research. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, and development of new research technology. Applicants are encouraged to conduct projects that ultimately have the potential to inform regulations on tobacco product manufacturing, distribution, and marketing. Research projects must address one or more High-Priority Research Topic(s) related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this NOFO will be administered by NIH using funds made available through FDA CTP and the FSPTCA. Research results from this NOFO are expected to generate findings and data directly relevant to informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.

Cyprus – Antineoplastic agents – Προσφορά για την προμήθεια Rituximab, Φ.Υ.Υ 11/2026 (OAY), Αρ.Φακ. 13.25.02.08.272

Poland – Medical consumables – ZAWARCIE UMOWY RAMOWEJ NA DOSTAWĘ IMPLANTÓW - 70 KPL.

Employee Assistance Program

Cyprus – Antineoplastic agents – Προσφορά για την Προμήθεια Carboplatin, Cladribine, Dacarbazine και Hydroxyurea, Αρ. Διαγωνισμού: 32/2026 (ΟΑΥ), Αρ. Φακ.: Φ.Y.Y.13.25.02.08.277

Denmark – Baby care products – EU-Udbud 2026: Barnevogne og klapvogne med og uden motor m.m.

The NICHD Small Research Grant Program (Clinical Trial Required) supports clinical trials that fall within the NICHD mission.

Poland – Parts and accessories for hearing aids – DOSTAWY PROCESORÓW DŹWIĘKU SYSTEMU IMPLANTU ŚLIMAKOWEGO

2026/27 Pre-Deployment Medical Screenings - Australian Antarctic Division

Poland – Orthopaedic prostheses – 132/PN/2026 - Dostawa implantów onkologicznych stosowanych w ortopedii dla UCK

Romania – Medical consumables – ACORD-CADRU FURNIZARE Materiale sanitare / Consumabile medicale

Spain – Company health services – Servicio de Prevencion Ajeno de la especialidad preventiva de Medicina del Trabajo, para la prestacion integra de la actividad preventiva de vigilancia de la salud

Spain – Disposable non-chemical medical consumables and haematological consumables – ALMERIA 1º CBAM CONTR 2026 0000190267_1

Cyprus – Systemic hormonal preparations, excl. sex hormones – Προσφορά για την προμήθεια Teriparatide, Aρ. Διαγωνισμού: 22/2026 (OAY)

Italy – Social services – PIA Uc Mont Emilius

Italy – Miscellaneous medical devices and products – Procedura aperta per l'affidamento della fornitura, suddivisa in lotti, di protesi di spalla occorrenti per ventiquattro mesi alla S.C. Ortopedia e Traumatologia dell'Azienda Ospedaliera S. Croce e Carle di Cuneo

Spain – Medical consumables – Suministro de material fungible para oxigenoterapia, aerosolterapia y espirometrías para la OSI Araba

Greece – Isotopic reagents – ΡΑΔΙΟΦΑΡΜΑΚΑ & ΡΑΔΙΟΪΣΟΤΟΠΙΚΑ ΑΝΤΙΔΡΑΣΤΗΡΙΑ

Poland – Pharmaceutical products – Sukcesywna dostawa leków i materiałów medycznych dla SPZOZ w Mławie

Spain – Health and social work services – Servicio De Limpieza, Lavanderia, Atencion Social, Seguridad Y Suministros Farmaceuticos En Salas 3 (T1), Y T4 (T4S) Rechazados En Frontera A.Adolfo

Croatia – Medical equipments – GAMA KAMERA

Croatia – Medicinal products for obstructive airway diseases – LIJEKOVI ZA LIJEČENJE OPSTRUKTIVNE BOLESTI DIŠNIH PUTEVA

Poland – Pacemaker – Dostawa wyrobów do zabiegów elektroterapii wraz z dzierżawą programatorów

Denmark – Immuno-analysis devices – Anskaffelse af Immunfarvemaskiner

Poland – Hospital and related services – Udzielanie świadczeń zdrowotnych

Health Technology Assessment and Support Services

Poland – Medical equipments – Zakup sprzętu medycznego i wyposażenia w ramach przedsięwzięcia pn.„Przebudowa części budynku zakaźnego celem rozwoju opieki długoterminowej wraz z termomodernizacją całego budynku w Wojewódzkim Szpitalu Specjalistycznym MEGREZ Sp. z o.o. realizowanego ze środków Krajowego Planu Odbudowy i Zwiększania Odporności: Komponent D „Efektywność, dostępność i jakość systemu ochrony zdrowia” inwestycja D

Croatia – Laboratory reagents – POTROŠNI MATERIJAL, TESTOVI I OSTALO ZA MIKROBIOLOGIJU

Poland – Orthopaedic implants – Zakup implantów ortopedycznych, implantów do zabiegów neurochirurgicznych, endoprotez oraz narzędzi medycznych - powtórka

Poland – Medical consumables – Dostawa łat i protez naczyniowych

Poland – Various medicinal products – Sukcesywna dostawa produktu leczniczego – Programy Lekowe_cz. I

Portugal – Pharmaceutical products – 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS]

Romania – Disposable nappies – Scutece de unica folosnta, aleze de unica folosinta, tampoane absorbante

Poland – Medical consumables – Dostawy bielizny operacyjnej i obłożeń

Latvia – Renal dialysis consumables – “Nepārtrauktās un intermitējošās nieru aizstājterapijas izejmateriālu piegāde”

Poland – Medical equipments – „Zakup systemu do śródoperacyjnej radiografii tkanek dla Copernicus PL Sp. z o.o.”

Health Technology Assessment

Italy – Miscellaneous medical devices and products – APPARATO RESPIRATORIO

Health Contribution to the National Poison Register

Bulgaria – Pharmaceutical products – ДОСТАВКА НА ЛЕКАРСТВЕНИ ПРОДУКТИ ЗА НУЖДИТЕ НА „МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ – ТУТРАКАН” ЕООД ПО ОБОСОБЕНИ ПОЗИЦИИ

Croatia – Disposable non-chemical medical consumables and haematological consumables – Medicinski potrošni materijal 1

Lithuania – Immunosuppressive agents – Medikamentas Satralizumabas

Czechia – Surgical gloves – Operační a vyšetřovací rukavice 2025

Bay Audio - RAP

Latvia – Laboratory reagents – Reaģentu, paligmateriālu un kontroles materiālu piegāde

Italy – Daycare services for handicapped children and young people – PROCEDURA APERTA EX ART. 71 D. LGS 36 2023 PER L’AFFIDAMENTO DELLA GESTIONE DEI CENTRI ESTIVI COMUNALI DAL 16 06 2025 AL 25 07 2025

Poland – Pharmaceutical products – NA SUKCESYWNĄ SPRZEDAŻ PRODUKTÓW FARMACEUTYCZNYCH DLA APTEKI SZPITALNEJ

Romania – Catheters – Catetere si Canule (2025)

Lithuania – Laboratory reagents – CPO Reagentų biocheminiams tyrimams pirkimas su analizatoriaus panauda ir technine priežiūra

Poland – Pharmaceutical products – Dostawa produktów farmaceutycznych dla Samodzielnego Publicznego Zakładu Opieki Zdrowotnej w Bochni Szpital Powiatowy im. bł. Marty Wieckiej cz. I.

Poland – Laboratory reagents – SZP.281.14.2026 – Dostawa odczynników wraz z dzierżawą sprzętu do wykonywania badań dla Instytutu „CZMP”

Provision of locum doctor services to Christmas Island

Romania – Medical consumables – Furnizare Materiale consumabile si obiecte de inventar Etapa IV-CANTAVAC 2.0

Poland – Medical equipments – Doposażenie oddziałów szpitalnych w aparaturę medyczną w ramach inwestycji „Modernizacja i rozwój bazy onkologicznej w Szpitalu Miejskim w Siemianowicach Śląskich Sp. z o. o.” II

Bulgaria – Pharmaceutical products – Периодична доставка на лекарствени продукти включени в Приложение №2 от ПЛС

Slovakia – Medical equipments – Systém na lokalizáciu nehmotných lézií prsníka

Emergency Medical Evacuation Services

Educational Activities about the National Lung Cancer Screening Program

Lithuania – Medical equipments – Medicininė įranga

Pathology Products

Medical training and education supplies